Zeinab Ghasemishahrestani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zeinab Ghasemishahrestani has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Ardeshir Bayat
Hair and Skin Research Laboratory, South African Medical Research Council (SAMRC) Wound Healing and Keloid Research Unit, Division of Dermatology, Department of Medicine, Faculty of Health Sciences, Groote Schuur Hospital, University of Cape Town, Cape Town 7700, South Africa
5 shared publications - Nonhlanhla Patience Khumalo
MRC-SA Wound Healing and Keloid Research Unit, Division of Dermatology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa
5 shared publications - Marcos Dias Pereira
Rede de Micologia RJ – FAPERJ
3 shared publications - Cintia Verdan
Universidade Federal do Rio de Janeiro
2 shared publications - Diego Viana-Gomes
Universidade Federal do Rio de Janeiro
2 shared publications - Gianna Mastroianni Kirsztajn
Universidade Federal de São Paulo
2 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Elsevier in Journal of Molecular Biology
- Vol. 439 (1)
Post-transcriptional Regulation of FGF Signaling: Insights From Musculoskeletal System
- 3 November 2026
- Published by Elsevier in Journal of Molecular Biology
- Vol. 439 (1)
Open AccessPost-transcriptional Regulation of FGF Signaling: Insights From Musculoskeletal System
- 25 June 2026
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 39 (4) , 742-750
Acute kidney injury induced by exertional rhabdomyolysis in military personnel
Background: Exertional rhabdomyolysis is a relatively common condition among military personnel and athletes, potentially leading to acute kidney injury. This study describes the occurrence of exertional rhabdomyolysis and pre-renal or intrinsic acute kidney injury in elite military personnel undergoing intense operational training, emphasizing readily accessible serum and urinary biochemical markers that may serve as early warning signs. Methods: The study included 19 recruits from the Brazilian Marine Corps who completed the Amphibious Command Course, involving rigorous training and dietary restrictions in a tropical mountainous region, from an initial group of 60 highly trained personnel. Exertional rhabdomyolysis was evaluated through serum creatine kinase, myoglobin, and lactate dehydrogenase. Kidney function was assessed using serum creatinine, urea and phosphate. Acute kidney injury was defined according to Acute Kidney Injury Network criteria. The diagnosis of pre-renal or intrinsic acute kidney injury was based on urinary sodium/potassium (uNa/uK) ratio, uK/(uK + uNa) ratio, fractional excretion of sodium, and fractional excretion of urea. Results: Post-training analyses showed significant increases in biomarkers of muscle and kidney damage. All participants developed exertional rhabdomyolysis, and nine presented with acute kidney injury, all of which were classified as pre-renal. In detail, serum CK, LDH, myoglobin, and AST significantly increased after physical exertion. CK levels then declined by the end of the mission and returned close to baseline after seven days. Conclusion: This exploratory study indicates a high frequency of exertional rhabdomyolysis and pre-renal acute kidney injury in this specific cohort of elite military personnel undergoing intense physical training. Given the limited sample size (n = 19), the findings should be considered preliminary. The identified biomarkers may assist in monitoring kidney function and muscle injury but require validation in larger and more diverse cohorts before broad clinical application.
- 25 June 2026
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 39 (4) , 742-750
Acute kidney injury induced by exertional rhabdomyolysis in military personnel
Background: Exertional rhabdomyolysis is a relatively common condition among military personnel and athletes, potentially leading to acute kidney injury. This study describes the occurrence of exertional rhabdomyolysis and pre-renal or intrinsic acute kidney injury in elite military personnel undergoing intense operational training, emphasizing readily accessible serum and urinary biochemical markers that may serve as early warning signs. Methods: The study included 19 recruits from the Brazilian Marine Corps who completed the Amphibious Command Course, involving rigorous training and dietary restrictions in a tropical mountainous region, from an initial group of 60 highly trained personnel. Exertional rhabdomyolysis was evaluated through serum creatine kinase, myoglobin, and lactate dehydrogenase. Kidney function was assessed using serum creatinine, urea and phosphate. Acute kidney injury was defined according to Acute Kidney Injury Network criteria. The diagnosis of pre-renal or intrinsic acute kidney injury was based on urinary sodium/potassium (uNa/uK) ratio, uK/(uK + uNa) ratio, fractional excretion of sodium, and fractional excretion of urea. Results: Post-training analyses showed significant increases in biomarkers of muscle and kidney damage. All participants developed exertional rhabdomyolysis, and nine presented with acute kidney injury, all of which were classified as pre-renal. In detail, serum CK, LDH, myoglobin, and AST significantly increased after physical exertion. CK levels then declined by the end of the mission and returned close to baseline after seven days. Conclusion: This exploratory study indicates a high frequency of exertional rhabdomyolysis and pre-renal acute kidney injury in this specific cohort of elite military personnel undergoing intense physical training. Given the limited sample size (n = 19), the findings should be considered preliminary. The identified biomarkers may assist in monitoring kidney function and muscle injury but require validation in larger and more diverse cohorts before broad clinical application.
- Top Cited PapersOpen Access
- 2 June 2026
- Published by Wiley in International Wound Journal
- Vol. 23 (6) , e70964
The In Vitro Wound‐Scratch Assay: Applications, Technical Advances, and Limitations in Wound Healing Research
The wound‐scratch assay is a widely used in vitro model for studying collective cell migration, a fundamental process contributing to wound closure and re‐epithelialisation. Owing to its simplicity, low cost, and adaptability, it has become a foundational tool for early‐stage wound‐healing research and therapeutic screening. The assay involves generating a defined gap in a confluent cell monolayer and monitoring gap closure over time as a surrogate readout of repair. This narrative review examined 199 published studies, identifying 73 relevant to wound healing. A technical hierarchy of wound creation methods was identified across three main categories: mechanical approaches (e.g., pipette tips and cell scrapers), accessible but prone to operator‐dependent variability; semi‐automated systems (e.g., inserts and wound maker devices), which improve reproducibility; and fully‐automated robotic platforms offering high precision and high‐throughput capability. While these advances enhance technical consistency, they do not overcome the assay's fundamental biological constraints. Importantly, gap closure in the wound‐scratch assay primarily reflects planar collective cell migration and does not recapitulate the integrated inflammatory, vascular, metabolic, and extracellular matrix‐dependent processes that govern wound repair in vivo. Consequently, bioactive compounds acting through antioxidant, anti‐inflammatory, angiogenic, or matrix‐modulating pathways may have their therapeutic potential underestimated or misclassified when assessed using migration‐only readouts. Preliminary in‐house (unpublished) data are presented to illustrate this limitation, demonstrating modest migration effects for compounds with established wound‐healing activity in vivo. Despite these limitations, the wound‐scratch assay remains a valuable first‐line, hypothesis‐generating tool when interpreted appropriately, with future utility dependent on integration with adapted models and complementary assays for translation.
- 2 June 2026
- Published by Wiley in International Wound Journal
- Vol. 23 (6) , e70964
Top Cited PapersOpen AccessThe In Vitro Wound‐Scratch Assay: Applications, Technical Advances, and Limitations in Wound Healing Research
The wound‐scratch assay is a widely used in vitro model for studying collective cell migration, a fundamental process contributing to wound closure and re‐epithelialisation. Owing to its simplicity, low cost, and adaptability, it has become a foundational tool for early‐stage wound‐healing research and therapeutic screening. The assay involves generating a defined gap in a confluent cell monolayer and monitoring gap closure over time as a surrogate readout of repair. This narrative review examined 199 published studies, identifying 73 relevant to wound healing. A technical hierarchy of wound creation methods was identified across three main categories: mechanical approaches (e.g., pipette tips and cell scrapers), accessible but prone to operator‐dependent variability; semi‐automated systems (e.g., inserts and wound maker devices), which improve reproducibility; and fully‐automated robotic platforms offering high precision and high‐throughput capability. While these advances enhance technical consistency, they do not overcome the assay's fundamental biological constraints. Importantly, gap closure in the wound‐scratch assay primarily reflects planar collective cell migration and does not recapitulate the integrated inflammatory, vascular, metabolic, and extracellular matrix‐dependent processes that govern wound repair in vivo. Consequently, bioactive compounds acting through antioxidant, anti‐inflammatory, angiogenic, or matrix‐modulating pathways may have their therapeutic potential underestimated or misclassified when assessed using migration‐only readouts. Preliminary in‐house (unpublished) data are presented to illustrate this limitation, demonstrating modest migration effects for compounds with established wound‐healing activity in vivo. Despite these limitations, the wound‐scratch assay remains a valuable first‐line, hypothesis‐generating tool when interpreted appropriately, with future utility dependent on integration with adapted models and complementary assays for translation.
- 17 October 2025
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (3) , 625-639
Cutaneous Immune Memory: A Double-Edged Sword in Skin Repair and Fibrosis
- 17 October 2025
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (3) , 625-639
Cutaneous Immune Memory: A Double-Edged Sword in Skin Repair and Fibrosis
- Open Access
- 17 August 2025
- Published by Wiley in International Wound Journal
- Vol. 22 (8) , e70742
African Medicinal Plants in Cutaneous Wound Repair: A Comprehensive Analysis of the Role of Phytochemicals
Chronic and non‐healing wounds are a global health issue with limited effective treatments. Wound care costs continue to rise, highlighting the need for new therapies. Medicinal plants, particularly African species, show promise for enhancing wound healing. This review analysed 93 studies and identified 37 relevant to wound healing, covering 39 plant species. Ten species were identified for their rich phytochemical content, specifically flavonoids, terpenoids, and alkaloids (plant‐derived compounds). These compounds act synergistically, enhancing the wound healing process at each stage. Flavonoids reduce inflammation and support tissue turnover, while terpenoids enhance collagen production and wound closure. Alkaloids offer antimicrobial benefits and support wound contraction. Notable plants include Ageratum conyzoides and Aspilia africana (Asteraceae family); promoting haemostasis by lowering plasma fibrinogen and enhancing platelet‐derived growth factors; Withania somnifera (Solanaceae); and Entada africana (Fabaceae), effectively regulating inflammation. In the proliferative phase, Ocimum gratissimum (Lamiaceae), Calendula officinalis (Asteraceae), and Centella asiatica (Apiaceae) although C. officinalis is native to Southern Europe, and C. asiatica an Asian‐native; they are widely used in African traditional medicine and included here for their relevance in African wound healing practices; Justicia flava (Acanthaceae), Alternanthera sessilis (Amaranthaceae), and Acalypha indica (Euphorbiaceae); play key roles in enhancing collagen production, angiogenesis, and re‐epithelialisation. This comprehensive analysis highlights the role of African medicinal plants in wound healing and their potential to improve wound care therapy.
- 17 August 2025
- Published by Wiley in International Wound Journal
- Vol. 22 (8) , e70742
Open AccessAfrican Medicinal Plants in Cutaneous Wound Repair: A Comprehensive Analysis of the Role of Phytochemicals
Chronic and non‐healing wounds are a global health issue with limited effective treatments. Wound care costs continue to rise, highlighting the need for new therapies. Medicinal plants, particularly African species, show promise for enhancing wound healing. This review analysed 93 studies and identified 37 relevant to wound healing, covering 39 plant species. Ten species were identified for their rich phytochemical content, specifically flavonoids, terpenoids, and alkaloids (plant‐derived compounds). These compounds act synergistically, enhancing the wound healing process at each stage. Flavonoids reduce inflammation and support tissue turnover, while terpenoids enhance collagen production and wound closure. Alkaloids offer antimicrobial benefits and support wound contraction. Notable plants include Ageratum conyzoides and Aspilia africana (Asteraceae family); promoting haemostasis by lowering plasma fibrinogen and enhancing platelet‐derived growth factors; Withania somnifera (Solanaceae); and Entada africana (Fabaceae), effectively regulating inflammation. In the proliferative phase, Ocimum gratissimum (Lamiaceae), Calendula officinalis (Asteraceae), and Centella asiatica (Apiaceae) although C. officinalis is native to Southern Europe, and C. asiatica an Asian‐native; they are widely used in African traditional medicine and included here for their relevance in African wound healing practices; Justicia flava (Acanthaceae), Alternanthera sessilis (Amaranthaceae), and Acalypha indica (Euphorbiaceae); play key roles in enhancing collagen production, angiogenesis, and re‐epithelialisation. This comprehensive analysis highlights the role of African medicinal plants in wound healing and their potential to improve wound care therapy.
- Open Access
- 30 July 2025
- Published by Elsevier in JID Innovations
- Vol. 5 (6) , 100402
Superior Antiproliferative and Enhanced Synergistic Effects of a ROCK Inhibitor in Multiple Models for Keloid Disease
- 30 July 2025
- Published by Elsevier in JID Innovations
- Vol. 5 (6) , 100402
Open AccessSuperior Antiproliferative and Enhanced Synergistic Effects of a ROCK Inhibitor in Multiple Models for Keloid Disease
- Open Access
- 2 December 2024
- Published by Qeios Ltd
- Vol. 6 (12)
Case Report: Urinary Proteomic Analysis of Exercise-Induced Rhabdomyolysis with Acute Kidney Injury
Exertional rhabdomyolysis (ER) is a frequently observed consequence following sustained strenuous exercise. The incidence of exercise-induced rhabdomyolysis has risen in the healthy population in recent decades, posing potential systemic, life-threatening complications like acute kidney injury (AKI). Early diagnosis requires prompt identification and management to prevent morbidity. This case report details the presentation of a 24-year-old male military member from the amphibious command specialization course, who attended the hospital emergency room with symptoms of nausea and dark brown urine 24 hours after strenuous military physical training. Laboratory results revealed a significant elevation in serum creatine kinase (CK) and creatinine (Cre) levels, reaching 9300 IU/L and 5.7 mg/dL, respectively. Concurrently, liver enzymes and urea levels were elevated, leading to the diagnosis of both ER and AKI. The individual exhibited a polygenic risk profile for ER, increasing susceptibility to inflammation and muscle damage. Further investigation through urine proteomic analysis unveiled the presence of various proteins associated with muscle damage, including creatine kinase M (CKM), myoglobin (MB), carbonic anhydrase (CA1), titin (TTN), as well as proteins linked to AKI, such as alpha-2-macroglobulin (A2MG), beta-2-microglobulin (B2MG), insulin-like growth factor-binding protein 7 (IBP7), metalloproteinase inhibitor 1 (TIMP1), and uromodulin (UROM), among others. Following a 12-day intensive care unit (ICU) treatment, a notable reduction in CK and MB levels was observed, accompanied by the restoration of renal function to normal levels. Subsequent laboratory tests during outpatient follow-up, two weeks after discharge, confirmed the normalization of relevant markers. The utilization of urinary proteomics emerged as a non-invasive method for monitoring pathophysiological changes, offering valuable insights into the mechanisms underlying ER and associated AKI.
- 2 December 2024
- Published by Qeios Ltd
- Vol. 6 (12)
Open AccessCase Report: Urinary Proteomic Analysis of Exercise-Induced Rhabdomyolysis with Acute Kidney Injury
Exertional rhabdomyolysis (ER) is a frequently observed consequence following sustained strenuous exercise. The incidence of exercise-induced rhabdomyolysis has risen in the healthy population in recent decades, posing potential systemic, life-threatening complications like acute kidney injury (AKI). Early diagnosis requires prompt identification and management to prevent morbidity. This case report details the presentation of a 24-year-old male military member from the amphibious command specialization course, who attended the hospital emergency room with symptoms of nausea and dark brown urine 24 hours after strenuous military physical training. Laboratory results revealed a significant elevation in serum creatine kinase (CK) and creatinine (Cre) levels, reaching 9300 IU/L and 5.7 mg/dL, respectively. Concurrently, liver enzymes and urea levels were elevated, leading to the diagnosis of both ER and AKI. The individual exhibited a polygenic risk profile for ER, increasing susceptibility to inflammation and muscle damage. Further investigation through urine proteomic analysis unveiled the presence of various proteins associated with muscle damage, including creatine kinase M (CKM), myoglobin (MB), carbonic anhydrase (CA1), titin (TTN), as well as proteins linked to AKI, such as alpha-2-macroglobulin (A2MG), beta-2-microglobulin (B2MG), insulin-like growth factor-binding protein 7 (IBP7), metalloproteinase inhibitor 1 (TIMP1), and uromodulin (UROM), among others. Following a 12-day intensive care unit (ICU) treatment, a notable reduction in CK and MB levels was observed, accompanied by the restoration of renal function to normal levels. Subsequent laboratory tests during outpatient follow-up, two weeks after discharge, confirmed the normalization of relevant markers. The utilization of urinary proteomics emerged as a non-invasive method for monitoring pathophysiological changes, offering valuable insights into the mechanisms underlying ER and associated AKI.
- Open Access
- 7 August 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (3) , 660-677.e8
Subcellular Fractionation and Metaproteogenomic Identification and Validation of Key Differentially Expressed Molecular Targets for Keloid Disease
- 7 August 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (3) , 660-677.e8
Open AccessSubcellular Fractionation and Metaproteogenomic Identification and Validation of Key Differentially Expressed Molecular Targets for Keloid Disease
- Open Access
- 3 August 2021
- Published by International Library of Science in Highlights in BioScience
- p. bs202108
ANN-based diagnosis method for skin cancers using dermoscopic images
Melanoma is one of the most dangerous skin cancers in the world. It accounts for 55% of all deaths associated with skin cancer. Researchers believe that skin cancer increases the risk of other cancers if not diagnosed early. Therefore, prompt and timely diagnosis of this disease is very important for the successful treatment of the patient. This system can detect melanoma lethal carcinoma from other skin lesions without the need for surgery, with a low cost, accuracy of about 98.88% and specificity 99%. In this article, a new, intelligent and accurate software (Delphi) system has been used to diagnose melanoma skin cancer. To detect malignant melanoma, the ABCDT rule, asymmetry (A), boundary (B), color (C), diameter (D) and textural variation (T) of the lesion are calculated and finally, an artificial neural network (ANN) is used to obtain an accurate result. The ANN with Multi-Layer Perceptron (MLP) contains the five extraction Characteristics (ABCDT) of lesions is used as inputs, two hidden layers, and two outputs. Very good results were obtained using this method. It was observed that for a dataset of 180 dermoscopic lesion images including 80 malignant melanomas, 20 benign melanomas and 80 nevus lesions. Due to its automatic recognition and ability to be installed on a computer, this system can be very useful for dermatologists as well as the general public.
- 3 August 2021
- Published by International Library of Science in Highlights in BioScience
- p. bs202108
Open AccessANN-based diagnosis method for skin cancers using dermoscopic images
Melanoma is one of the most dangerous skin cancers in the world. It accounts for 55% of all deaths associated with skin cancer. Researchers believe that skin cancer increases the risk of other cancers if not diagnosed early. Therefore, prompt and timely diagnosis of this disease is very important for the successful treatment of the patient. This system can detect melanoma lethal carcinoma from other skin lesions without the need for surgery, with a low cost, accuracy of about 98.88% and specificity 99%. In this article, a new, intelligent and accurate software (Delphi) system has been used to diagnose melanoma skin cancer. To detect malignant melanoma, the ABCDT rule, asymmetry (A), boundary (B), color (C), diameter (D) and textural variation (T) of the lesion are calculated and finally, an artificial neural network (ANN) is used to obtain an accurate result. The ANN with Multi-Layer Perceptron (MLP) contains the five extraction Characteristics (ABCDT) of lesions is used as inputs, two hidden layers, and two outputs. Very good results were obtained using this method. It was observed that for a dataset of 180 dermoscopic lesion images including 80 malignant melanomas, 20 benign melanomas and 80 nevus lesions. Due to its automatic recognition and ability to be installed on a computer, this system can be very useful for dermatologists as well as the general public.
- 1 June 2021
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 28 (18) , 3514-3534
Pieces of the Complex Puzzle of Cancer Cell Energy Metabolism: An Overview of Energy Metabolism and Alternatives for Targeted Cancer Therapy
Over the past decades, several advances in cancer cell biology have led to relevant details about a phenomenon called the ‘Warburg effect’. Currently, it has been accepted that the Warburg effect is not compatible with all cancer cells, and thus the process of aerobic glycolysis is now challenged by the knowledge of a large number of cells presenting mitochondrial function. The energy metabolism of cancer cells is focused on the bioenergetic and biosynthetic pathways in order to meet the requirements of rapid proliferation. Changes in the metabolism of carbohydrates, amino acids and lipids have already been reported for cancer cells and this might play an important role in cancer progression. To the best of our knowledge, these changes are mainly attributed to genetic reprogramming which leads to the transformation of a healthy into a cancerous cell. Indeed, several enzymes that are highly relevant for cellular energy are targets of oncogenes (e.g. PI3K, HIF1, and Myc) and tumor suppressor proteins (e.g. p53). As a consequence of extensive studies on cancer cell metabolism, some new therapeutic strategies have appeared that aim to interrupt the aberrant metabolism, in addition to influencing genetic reprogramming in cancer cells. In this review, we present an overview of cancer cell metabolism (carbohydrate, amino acid, and lipid), and also describe oncogenes and tumor suppressors that directly affect the metabolism. We also discuss some of the potential therapeutic candidates which have been designed to target and disrupt the main driving forces associated with cancer cell metabolism and proliferation.
- 1 June 2021
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 28 (18) , 3514-3534
Pieces of the Complex Puzzle of Cancer Cell Energy Metabolism: An Overview of Energy Metabolism and Alternatives for Targeted Cancer Therapy
Over the past decades, several advances in cancer cell biology have led to relevant details about a phenomenon called the ‘Warburg effect’. Currently, it has been accepted that the Warburg effect is not compatible with all cancer cells, and thus the process of aerobic glycolysis is now challenged by the knowledge of a large number of cells presenting mitochondrial function. The energy metabolism of cancer cells is focused on the bioenergetic and biosynthetic pathways in order to meet the requirements of rapid proliferation. Changes in the metabolism of carbohydrates, amino acids and lipids have already been reported for cancer cells and this might play an important role in cancer progression. To the best of our knowledge, these changes are mainly attributed to genetic reprogramming which leads to the transformation of a healthy into a cancerous cell. Indeed, several enzymes that are highly relevant for cellular energy are targets of oncogenes (e.g. PI3K, HIF1, and Myc) and tumor suppressor proteins (e.g. p53). As a consequence of extensive studies on cancer cell metabolism, some new therapeutic strategies have appeared that aim to interrupt the aberrant metabolism, in addition to influencing genetic reprogramming in cancer cells. In this review, we present an overview of cancer cell metabolism (carbohydrate, amino acid, and lipid), and also describe oncogenes and tumor suppressors that directly affect the metabolism. We also discuss some of the potential therapeutic candidates which have been designed to target and disrupt the main driving forces associated with cancer cell metabolism and proliferation.